Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Complications of chemotherapy (agents listed below)
Some callers report using five times the dosage administered in clinical trials
Data from real-world patient reports suggest that 60-70% of users experience complete nausea resolution by week 8-12 of therapy, regardless of final maintenance dose
Additional non-oral contraception is advised for 4 weeks after starting treatment and for 4 weeks after each dose increase If pancreatitis is suspected (severe, persistent abdominal pain with or without vomiting), stop Mounjaro immediately and seek urgent medical assessment Mounjaro is not indicated for type 1 diabetes or diabetic ketoacidosis The medication is not recommended during pregnancy or breastfeeding Patients should report any suspected side effects via the MHRA Yellow Card Scheme
Eli Lilly has a program where some doses of Zepbound are available as a vial/syringe in addition to injection via needle
